CartiHeal ⚠ Under review

Under review — some data on this profile may be inaccurate and is being re-verified.

Developer of proprietary implants for the treatment of cartilage and osteochondral defects in traumatic and osteoarthritic joints.

Health Tech & Life Sciences
Acquired by Smith & Nephew
Acquired Kefar Sava, Israel Founded 2009
Last updated 2026-07-20
Total raised
$74.0M
Last: G Round 2020-07
Stage
Acquired
Founded
2009
Headcount
25
HQ
Kefar Sava, Israel
Sector
Health Tech & Life Sciences

About

CartiHeal is an Israeli medical device company that develops proprietary implants for the treatment of cartilage and osteochondral defects in traumatic and osteoarthritic joints. Their flagship product, Agili-C, is a cell-free, off-the-shelf implant made from aragonite (a form of calcium carbonate derived from coral exoskeletons) that promotes the natural regeneration of articular cartilage and restoration of underlying subchondral bone. The Agili-C implant received FDA Breakthrough Device Designation in 2020 and PMA approval in March 2022. It has demonstrated superior clinical performance compared to the surgical standard of care, including significant pain relief and functional gains, and a reduced risk of total knee replacement.

Funding history · 7 rounds · $74.0M total

2020-06
G Round $15.0M
★ Bioventus
2017-04
F Round $21.0M
★ Bioventus★ aMoon Fund★ Elron Ventures★ Peregrine Ventures★ Johnson & Johnson Innovation
2015-12
E Round $15.0M
★ Accelmed★ Elron Ventures★ Peregrine Ventures★ Access Medical Ventures★ Johnson & Johnson Innovation
2015-01
D Round $3.0M
★ Elron Ventures
2013-09
C Round $5.0M
★ Accelmed★ Elron Ventures★ Access Medical Ventures
2012-06
B Round $10.0M
★ Accelmed★ Elron Ventures★ Access Medical Ventures
2012-01
A Round $5.0M
★ Accelmed★ Incentive★ Access Medical Ventures

Headcount over time

From 18 (2018-08) to 17 (2025-12) · -1 (-6%) · 32 points · source: Finder history + radar grounding
270 2018-08 2025-12

Q&A

When was CartiHeal acquired and by whom?
CartiHeal was acquired by Smith & Nephew in November 2023 for an amount of $330,000,000.
What is CartiHeal's primary product?
CartiHeal develops Agili-C, a cell-free, off-the-shelf implant for treating cartilage and osteochondral defects in traumatic and osteoarthritic joints.
What is the status of CartiHeal's Agili-C implant with the US FDA?
In October 2020, CartiHeal's Agili-C implant was granted breakthrough device designation by the US FDA.
How many employees does CartiHeal have?
CartiHeal has 11-50 employees.
What was CartiHeal's last funding round?
CartiHeal's last funding round was a G Round in July 2020, with Bioventus as the lead investor.
What is the total amount of funding CartiHeal raised?
CartiHeal raised a total of $74,000,000 USD across all its funding rounds.
Which investors participated in CartiHeal's F Round?
The F Round in May 2017 included investments from Peregrine Ventures and Johnson & Johnson Innovation.
Where is CartiHeal headquartered?
CartiHeal is headquartered in Kefar Sava, Center District, Israel.

Team · 1

Nir Altschuler
Founder · Founder & CEO

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Technologies
Materials & SubstancesImplants
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B

Highlights

1 Patents

Tags

rehabilitationbiodegradableminimally-invasivemedical-technologiesosteoarthritisregenerative-medicineorthopedics
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websitecartiheal.com
LinkedInlinkedin.com/company/1031481

Identifiers & details

Legal nameCARTIHEAL (2009) LTD
Founded2009
Employees (exact)25
OfficesCloster
Status reasonAcquired by Bioventus on May, 2022

Acquisitions & public offerings

Acquired by Smith & Nephew 2023-11 $330.0M

Radar intelligence

Patents

EPO15

Publications (Crossref)

Works4

Web history (Wayback)

Domaincartiheal.com

Certificate / subdomain footprint

Subdomains13

Israeli Companies Registrar (רשם החברות / ICA)

Registrar # (ח.פ.)514279645
Statusפעילה
Corp typeישראלית חברה פרטית
Incorporated2009-06-04
Purposeלעסוק בכל עיסוק חוקי
Liabilityמוגבלת
In violation (unfiled)yes
Last annual report2022
Active charges / liens0
Registry events0
Registered addressעתירי ידע 17 כפר סבא